Literature DB >> 2947082

[Absorption, distribution and elimination of a labelled extract of Ginkgo biloba leaves in the rat].

J P Moreau, C R Eck, J McCabe, S Skinner.   

Abstract

The absorption, distribution and elimination of a radiolabelled 14C extract prepared from Ginkgo biloba leaves have been studied in rats. Following oral administration, expired 14C-CO2 represented 16% of the administered dose excreted within the first 3 hours post-dose out of a total of 38% after 72 hours. An additional 21% of the administered dose was eliminated in the urine. The absorption of the radiolabelled Ginkgo biloba extract was at least 60%. The pharmacokinetics of the drug, based on blood specific activity data versus time course, were characteristic of a two-compartment model with an apparent first order phase and a biological half-life of approximatively 4.5 h. During the first 3 hours, radioactivity was primarily associated with the plasma, but through a gradual uptake after 48 h. The specific activity in erythrocytes matched that of plasma. A site of absorption in the upper gastrointestinal tract is suspected since specific activity in blood peaked after 1.5 hours. Glandular and neuronal tissues and eyes showed a high affinity for the labelled substance. These results provide the first tentative link between the therapeutic effectiveness of Ginkgo biloba extract and the biological fate of some of its constituents.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947082

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  5 in total

Review 1.  Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.

Authors:  Christian Ude; Manfred Schubert-Zsilavecz; Mario Wurglics
Journal:  Clin Pharmacokinet       Date:  2013-09       Impact factor: 6.447

2.  Comparative Electropharmacological Actions of Some Constituents from Ginkgo biloba Extract in Guinea-pig Ventricular Cardiomyocytes.

Authors:  Hiroyasu Satoh
Journal:  Evid Based Complement Alternat Med       Date:  2004-10-27       Impact factor: 2.629

Review 3.  Pharmacokinetic, Metabolism, and Metabolomic Strategies Provide Deep Insight Into the Underlying Mechanism of Ginkgo biloba Flavonoids in the Treatment of Cardiovascular Disease.

Authors:  Yi Tao; Fei Zhu; Meiling Pan; Qing Liu; Ping Wang
Journal:  Front Nutr       Date:  2022-03-23

4.  A double-blind, randomised cross-over study to evaluate the absorption of a commercially available Ginkgo biloba extract compared to the liposomal extract Ginkgosome.

Authors:  David Briskey; Amanda Rao
Journal:  BMC Complement Med Ther       Date:  2022-08-03

Review 5.  The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention.

Authors:  Brian Giunta; Demian Obregon; Renuka Velisetty; Paul R Sanberg; Cesar V Borlongan; Jun Tan
Journal:  J Neuroinflammation       Date:  2012-08-01       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.